Paper3936738
Sulphonylurea therapy doubles B-cell response to glucose in type 2 diabetic patients.
Hosker JP and 4 others. Diabetologia, 1985. Cited by 61 papers, by iCite.
Cite this record
ConductScience Library. Sulphonylurea therapy doubles B-cell response to glucose in type 2 diabetic patients. Papers, record 3936738. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3936738
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diabetes Mellitus, Type 2 | Major topic |
| Glucose | Major topic |
| Islets of Langerhans | Major topic |
| Sulfonylurea Compounds | Major topic |
| Aged | |
| Blood Glucose | |
| C-Peptide | |
| Chlorpropamide | |
| Glyburide | |
| Humans | |
| Hyperglycemia | |
| Insulin | |
| Insulin Resistance | |
| Middle Aged |
Source PubMed
References30
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6121186 | Relative contributions of insulin deficiency and insulin resistance in maturity-onset diabetes. | Lancet | 1982 | https://conductscience.org/library/papers/6121186 | PubMed |
| 2 | 913926 | Plasma insulin and glucose levels in maturity onset diabetics treated with chlorpropamide. | Diabetologia | 1977 | https://conductscience.org/library/papers/913926 | PubMed |
| 3 | 14318586 | FAILURE OF PROLONGED SULFONYLUREA ADMINISTRATION TO ENHANCE INSULOGENIC RESPONSE TO GLYCEMIC STIMULUS. | Diabetes | 1965 | https://conductscience.org/library/papers/14318586 | PubMed |
| 4 | 7045153 | Chronic chlorpropamide therapy of noninsulin-dependent diabetes augments basal and stimulated insulin secretion by increasing islet sensitivity to glucose. | J Clin Endocrinol Metab | 1982 | https://conductscience.org/library/papers/7045153 | PubMed |
| 5 | 565457 | Basal normoglycemia attained with chlorpropamide in mild diabetes. | Metabolism | 1978 | https://conductscience.org/library/papers/565457 | PubMed |
| 6 | 849812 | The effect of chronic oral antidiabetic therapy on insulin and glucagon responses to a meal. | Diabetes | 1977 | https://conductscience.org/library/papers/849812 | PubMed |
| 7 | 7009650 | Selective potentiation of insulin-mediated glucose disposal in normal dogs by the sulfonylurea glipizide. | J Clin Invest | 1981 | https://conductscience.org/library/papers/7009650 | PubMed |
| 8 | 175653 | Effects of sulfonylurea therapy on insulin binding to mononuclear leukocytes of diabetic patients. | Am J Med | 1976 | https://conductscience.org/library/papers/175653 | PubMed |
| 9 | 7287908 | Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus. | J Clin Invest | 1981 | https://conductscience.org/library/papers/7287908 | PubMed |
| 10 | 345754 | Effects of glipizide and food intake on the blood levels of glucose and insulin in diabetic patients. | Acta Med Scand | 1978 | https://conductscience.org/library/papers/345754 | PubMed |
| 11 | 6759080 | The long-term effects of chlorpropamide on insulin, C-peptide, and proinsulin secretion. | Diabetes Care | 1982 | https://conductscience.org/library/papers/6759080 | PubMed |
| 12 | 6337899 | Potentiation of insulin action by a sulfonylurea in primary cultures of hepatocytes from normal and diabetic rats. | Diabetes | 1983 | https://conductscience.org/library/papers/6337899 | PubMed |
| 13 | 6028757 | Effect of chlorpropamide on serum glucose and immunoreactive insulin concentrations in patients with maturity-onset diabetes mellitus. | Diabetes | 1967 | https://conductscience.org/library/papers/6028757 | PubMed |
| 14 | 446907 | Maintenance of basal plasma glucose and insulin concentrations in maturity-onset diabetes. | Diabetes | 1979 | https://conductscience.org/library/papers/446907 | PubMed |
| 15 | 631443 | Kinetics of human C-peptide in man. | Diabetes | 1978 | https://conductscience.org/library/papers/631443 | PubMed |
| 16 | 740034 | Sulphonylureas increase the number of insulin receptors. | Nature | 1978 | https://conductscience.org/library/papers/740034 | PubMed |
| 17 | 6781962 | Hormonal and metabolic effects of chlorpropamide, glibenclamide and placebo in a cross-over study in diabetics not controlled by diet alone. | Diabetologia | 1981 | https://conductscience.org/library/papers/6781962 | PubMed |
| 18 | 5052977 | Effect of chronic sulfonylurea therapy on plasma insulin and proinsulin levels. | J Clin Endocrinol Metab | 1972 | https://conductscience.org/library/papers/5052977 | PubMed |
| 19 | 4136696 | Effect of short and long term chlorpropamide treatment of insulin release and blood-glucose. | Lancet | 1974 | https://conductscience.org/library/papers/4136696 | PubMed |
| 20 | 1151775 | Insulin-stimulated entry of glucose into muscle in vivo as a major factor in the regulation of blood glucose. | J Physiol | 1975 | https://conductscience.org/library/papers/1151775 | PubMed |
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 61 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 30471094 | Hypoglycaemic effects of glimepiride in sulfonylurea receptor 1 deficient rat. | Br J Pharmacol | 2019 | https://conductscience.org/library/papers/30471094 | PubMed |
| 25810041 | Within-class differences of the sulfonylureas should be accounted for. Reply to Schrijnders D, Kleefstra N and Landman GWD [letter]. | Diabetologia | 2015 | https://conductscience.org/library/papers/25810041 | PubMed |
| 25297572 | The effect of glibenclamide on insulin secretion at normal glucose concentrations. | Diabetologia | 2015 | https://conductscience.org/library/papers/25297572 | PubMed |
| 23564921 | Expansion of the homeostasis model assessment of β-cell function and insulin resistance to enable clinical trial outcome modeling through the interactive adjustment of physiology and treatment effects: iHOMA2. | Diabetes Care | 2013 | https://conductscience.org/library/papers/23564921 | PubMed |
| 22815837 | Dietary fibre improves first-phase insulin secretion in overweight individuals. | PLoS One | 2012 | https://conductscience.org/library/papers/22815837 | PubMed |
| 10641958 | The use of sulphonylureas in the elderly. | Drugs Aging | 1999 | https://conductscience.org/library/papers/10641958 | PubMed |
| 8521759 | Prevention of complications in non-insulin-dependent diabetes mellitus (NIDDM). | Drugs | 1995 | https://conductscience.org/library/papers/8521759 | PubMed |
| 8461648 | Association of low birth weight with beta cell function in the adult first degree relatives of non-insulin dependent diabetic subjects. | BMJ | 1993 | https://conductscience.org/library/papers/8461648 | PubMed |
| 7966113 | Tablet and insulin therapy in type 2 diabetes in the elderly. | J R Soc Med | 1994 | https://conductscience.org/library/papers/7966113 | PubMed |
| 7958542 | Comparative dose-related time-action profiles of glibenclamide and a new non-sulphonylurea drug, AG-EE 623 ZW, during euglycaemic clamp in healthy subjects. | Diabetologia | 1994 | https://conductscience.org/library/papers/7958542 | PubMed |
| 7848543 | Comparative tolerability profiles of oral antidiabetic agents. | Drug Saf | 1994 | https://conductscience.org/library/papers/7848543 | PubMed |
| 3538736 | Insulin secretion and insulin sensitivity defects are a common feature of mild, clinically homogeneous, recently diagnosed type II (non-insulin-dependent) diabetics. | Acta Diabetol Lat | 1986 | https://conductscience.org/library/papers/3538736 | PubMed |
| 3301149 | The relationship between the pharmacokinetics and pharmacodynamic effects of oral hypoglycaemic drugs. | Clin Pharmacokinet | 1987 | https://conductscience.org/library/papers/3301149 | PubMed |
| 2656043 | Pharmacokinetic-pharmacodynamic relationships of oral hypoglycaemic agents. An update. | Clin Pharmacokinet | 1989 | https://conductscience.org/library/papers/2656043 | PubMed |
| 2528491 | Long-term gliclazide treatment improves the in vitro glucose-induced insulin release in rats with type 2 (non-insulin-dependent) diabetes induced by neonatal streptozotocin. | Diabetologia | 1989 | https://conductscience.org/library/papers/2528491 | PubMed |
| 1907623 | Chronic exposure to glibenclamide impairs insulin secretion in isolated rat pancreatic islets. | J Endocrinol Invest | 1991 | https://conductscience.org/library/papers/1907623 | PubMed |
| 1777653 | Effect of sulphonylurea on glucose-stimulated insulin secretion in healthy and non-insulin dependent diabetic subjects: a dose-response study. | Acta Diabetol | 1991 | https://conductscience.org/library/papers/1777653 | PubMed |
| 1560186 | Studies on the mechanism of action of sulphonylureas in type II diabetic subjects: gliquidone. | J Endocrinol Invest | 1992 | https://conductscience.org/library/papers/1560186 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| INS | 3630 | PubTator's text mining | https://conductscience.org/library/genes/3630 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3936738
GET https://conductscience.org/api/papers/v1/3936738/references?page=2